SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008535
Filing Date
2024-05-21
Accepted
2024-05-21 16:15:26
Documents
13
Period of Report
2024-05-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240516x8k.htm   iXBRL 8-K 41696
  Complete submission text file 0001558370-24-008535.txt   160362

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20240516.xsd EX-101.SCH 3136
3 EX-101.LAB tmb-20240516_lab.xml EX-101.LAB 15265
4 EX-101.PRE tmb-20240516_pre.xml EX-101.PRE 9929
16 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240516x8k_htm.xml XML 4668
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 24969539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)